About INDEE. INC.
Indee Labs develops Hydropore™, a non-viral technology for delivering genetic material to immune cells, enabling rapid and efficient cell therapy research and manufacturing. The company focuses on scalable, high-quality cell engineering solutions.
Non-viral delivery of small molecules, nucleic acids, proteins, and gene-editing complexes to immune cellsRapid delivery in seconds with high cell viability and functionScalable and efficient cell therapy development and manufacturingHigh-throughput pooled screening of small volumesRegulatory-ready technology development
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TOPIC 397 - MICROFLUIDIC VORTEX SHEDDING: A LOW-COST, HIGH EFFICIENCY METHOD FOR GENETIC MODIFICATION TO SUPPO | Department of Health and Human Services | $2.0M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INDEE. INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.